Complete remission of psoriasis following bevacizumab therapy for colon cancer

Clinical and Experimental Dermatology

Volumn 34, Issue 5, 2009, Pages

  Akman, A ^a,b   Yilmaz, E ^a   Mutlu, H ^a   Ozdogan, M ^a  

^a School of Medicine Antalya   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COLON CANCER; GENERAL CONDITION IMPROVEMENT; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSORIASIS; REMISSION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PSORIASIS; REMISSION INDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66449131988     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02991.x     Document Type: Article

References (10)

1. Wilson JF. Angiogenesis therapy moves beyond cancer. Ann Intern Med 2004 141 : 165 8.
2. Salesi N, Bossone G, Veltri E et al. Clinical experience with bevacizumab in colorectal cancer. Anticancer Res 2005 25 : 3619 23.
3. Malhotra R, Stenn KS, Fernandez LA, Braverman IM. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 1989 61 : 162 5.
4. Bhushan M, Young HS, Brenchley PEC, Griffiths CEM. Recent advances in cutaneous angiogenesis. Br J Dermatol 2002 147 : 418 25.
5. Sauder DN, Dekoven J, Champagne P et al. Neovastat (AE-941), an inhibitor of angiogenesis: randomized phase I/II clinical trial results in patients with plaque psoriasis. J Am Acad Dermatol 2002 47 : 535 41.
6. Detmar M, Brown LF, Claffey KP et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994 180 : 1141 6.
7. Akman A, Dicle O, Yilmaz F et al. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB. Photodermatol Photoimmunol Photomed 2008 24 : 123 7.
8. Young HS, Summers AM, Read IR et al. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J Invest Dermatol 2006 126 : 453 9.
9. Ooyama A, Oka T, Zhao HY et al. Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. Cancer Lett 2008 267 : 26 36.
10. Kaneko S, Ishibashi M, Kaneko M. Vascular endothelial growth factor expression is closely related to irinotecan-mediated inhibition of tumor growth and angiogenesis in neuroblastoma xenografts. Cancer Sci 2008 99 : 1209 17.